CCR2 and non-small cell lung carcinoma: Overall, these data underline the clinical relevance of the CCL2 gradient in primary lesions and brain metastases of NSCLC and that the CCL2/CCR2 axis can be genetically manipulated to promote CAR-T cell migration toward the CCL2 gradient.